Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Advocates often highlight the opportunity for significant therapeutic outcomes, particularly in conditions where conventional medications have proven limited. However, this is to evaluate the substantial financial expenditure associated with CPI stem c